IQVIA (IQV)
(Delayed Data from NYSE)
$234.08 USD
+4.88 (2.13%)
Updated May 10, 2024 04:00 PM ET
After-Market: $234.12 +0.04 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum C VGM
Price, Consensus and EPS Surprise
IQV 234.08 +4.88(2.13%)
Will IQV be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for IQV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IQV
What's in Store for International Money's (IMXI) Q1 Earnings?
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
IQV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
IQVIA (IQV) Surpasses Earnings & Revenue Estimates in Q1
IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates
Other News for IQV
IQVIA Holdings Announces Executive Team Reshuffle and Role Change
IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024
Cedar Creek Partners - Propel Media: Dividends Are A Nice BonusĀ While We Wait
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
Stifel Nicolaus Keeps Their Buy Rating on IQVIA Holdings (IQV)